These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 7589037)
21. A proposed change in the classification of new drug clinical evaluations. Silson JE J Clin Pharmacol J New Drugs; 1968; 8(5):285-94. PubMed ID: 4877184 [No Abstract] [Full Text] [Related]
22. Understanding the FDA's guarded system for classifying new drugs. Schneiweiss F Hosp Pharm; 1979 May; 14(5):262-4, 266, 268 passim. PubMed ID: 10316828 [No Abstract] [Full Text] [Related]
23. The Food and Drug Administration's over-the-counter drug review: why review OTC drugs? Moxley JH; Yingling GL; Edwards CC Fed Proc; 1973 Apr; 32(4):1435-7. PubMed ID: 4701750 [No Abstract] [Full Text] [Related]
24. Drugs, codes, standards, and other incompatible things in the dark. Chute CG MD Comput; 2001; 18(1):45-6. PubMed ID: 11236386 [No Abstract] [Full Text] [Related]
25. U.S. Food and Drug Administration. "Evaluation Criteria" for Difficult to Compound Drugs. Allen LV Int J Pharm Compd; 2015; 19(6):487-8. PubMed ID: 26891563 [TBL] [Abstract][Full Text] [Related]
26. The nurse consultant's role in products liability litigation. Davis SC Natl Med Leg J; 1992; 3(1):1, 6-7. PubMed ID: 1728938 [No Abstract] [Full Text] [Related]
28. Classification and coding considerations for drug data base design. Forbes MB J Clin Comput; 1983; 12(3):88-100. PubMed ID: 10317426 [No Abstract] [Full Text] [Related]
29. Important new drugs of the year. Hussar DA Am Pharm; 1979 May; 19(5):25-33. PubMed ID: 474391 [No Abstract] [Full Text] [Related]
30. Class labeling: FDA concepts and approach. Lewis BP Am Pharm; 1980 Feb; NS20(2):40-2. PubMed ID: 7355710 [No Abstract] [Full Text] [Related]
31. Raising the bar. Barcoding has the potential to dramatically reduce medication errors. Goth G Healthc Inform; 2006 Apr; 23(4):38-41. PubMed ID: 16676641 [No Abstract] [Full Text] [Related]
32. Track-and-trace technology slowly progresses. Thompson CA Am J Health Syst Pharm; 2007 Dec; 64(23):2416-20. PubMed ID: 18029944 [No Abstract] [Full Text] [Related]
33. Self-medication. Fink JL Am J Pharm Sci Support Public Health; 1976; 148(3):90-6. PubMed ID: 984182 [No Abstract] [Full Text] [Related]
34. Teratogenic drugs and their drug interactions with hormonal contraceptives. Ahn MR; Li L; Shon J; Bashaw ED; Kim MJ Clin Pharmacol Ther; 2016 Sep; 100(3):217-9. PubMed ID: 27090193 [TBL] [Abstract][Full Text] [Related]
35. THE RECLASSIFICATION OF DRUGS. TICE LV Am J Pharm Sci Support Public Health; 1964; 136():180-2. PubMed ID: 14239446 [No Abstract] [Full Text] [Related]
36. [FOODS-DRUGS-POISONS. ELEMENTS OF DEFINITION]. TREMOLIERES J J Med Chir Prat; 1964 Oct; 135():339-47. PubMed ID: 14225293 [No Abstract] [Full Text] [Related]
37. The drug-potency question. Walker JM US Navy Med; 1974 Aug; 64(2):26-30. PubMed ID: 4534296 [No Abstract] [Full Text] [Related]
38. Drug safety: Pregnancy rating classifications and controversies. Wilmer E; Chai S; Kroumpouzos G Clin Dermatol; 2016; 34(3):401-9. PubMed ID: 27265079 [TBL] [Abstract][Full Text] [Related]
39. Prescription of medications during pregnancy: accidents, compromises, and uncertainties. Hernández-Díaz S Pharmacoepidemiol Drug Saf; 2006 Sep; 15(9):613-7. PubMed ID: 16941520 [No Abstract] [Full Text] [Related]
40. FDA gets advice on Modernization Act compliance. Marwick C JAMA; 1998 Oct; 280(14):1214-5. PubMed ID: 9786361 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]